Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

4.060 +0.020 (+0.50%)
Streaming Delayed Price Updated: 9:58 AM EST, Jan 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Precision BioSciences Appoints Alex Kelly as Chief Financial Officer
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Participate in the Jefferies Virtual Healthcare Conference
From Precision BioSciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Enveric Biosciences (NASDAQ:ENVB)... 
Via Benzinga
News headline image
Precision BioSciences' CD-19 CAR T Therapy Shows Response Rate Of 77% In Lymphoma Trial ↗
Precision BioSciences Inc (NASDAQ: DTIL) announced additional data from its Phase 1/2a study evaluating PBCAR0191, off-the-shelf, allogeneic CAR T candidate... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:... 
Via Benzinga
News headline image
Precision BioSciences to Present Data from its First Generation CD19 Allogeneic CAR T Program in Relapsed/Refractory Non-Hodgkin Lymphoma at the 2021 American Society of Clinical Oncology Meeting
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Recap: Precision BioSciences Q1 Earnings ↗
Shares of Precision BioSciences (NASDAQ:DTIL) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were up 36.54% year over year to ($... 
Via Benzinga
News headline image
Precision BioSciences Reports First Quarter and 2021 Financial Results and Provides Business Update
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Why Precision BioSciences Stock Is Trading Higher Today ↗
Precision BioSciences (NASDAQ: DTIL) shares are trading higher after the company reported its ARCUS platform showed a promising gene editing approach for transthyretin... 
Via Benzinga
News headline image
Precision BioSciences Shares Move Higher As ARCUS Platform Shows Promising Gene Editing Approach For Transthyretin Amyloidosis ↗
Precision BioSciences Inc (NASDAQ: DTIL) has announced new in vivo data using ARCUS genome editing platform resulting from a preclinical research... 
Via Benzinga
News headline image
New Preclinical Data Presented at the 2021 American Society of Genetic & Cell Therapy Annual Meeting Highlights Precision BioSciences’ ARCUS In Vivo Genome Editing
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Report First Quarter 2021 Financial Results on May 13, 2021
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Announces Paper Presentation at the Association for Research in Vision and Ophthalmology 2021 Annual Meeting
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Announces Poster Presentation at the Upcoming American Society of Gene & Cell Therapy Annual Meeting
From Precision BioSciences, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Precision BioSciences Appoints Renowned Hematologist Alan List, M.D. as Chief Medical Officer
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Reacquires Global Rights to its Allogeneic CAR T Programs
From Precision BioSciences Inc.
Via Business Wire
News headline image
Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Participate in the Truist Securities 2021 Life Sciences Virtual Series
From Precision BioSciences Inc.
Via Business Wire
News headline image
51 Biggest Movers From Yesterday ↗
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6... 
Via Benzinga
Topics Initial Public Offering
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.